<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Canadian Pharmacy Blog</title>
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.1.2" -->

	<item>
		<title>High-Risk Patients and High-Dose Intravenous Immune Globulin</title>
		<description><![CDATA[Caution is imperative when high doses of intravenous immune globulin (IVIg) treatment are given to obese patients and to patients with risk factors for thrombosis, say researchers who reported on two cases of thrombotic complications. One patient, with idiopathic thrombo-cytopenic purpura, received 1 g/kg of IVIg per day as a five-hour infusion daily for two [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/high-risk-patients-and-high-dose-intravenous-immune-globulin/</link>
			</item>
	<item>
		<title>Coxibs Can Go It Alone</title>
		<description><![CDATA[Although cyclooxygenase 2 (COX-2) inhibitors, also called &#8220;coxibs,&#8221; can be easier on the gastrointestinal system than nonsteroidal anti-inflammatory drugs (NSAIDs are, some physicians prefer to err on the side of caution by prescribing a gastroprotective agent (GPA) as well. The coxibs were named after two recently developed anti-inflammatory drugs, canadian celecoxib (Celebrex drug, Pharmacia) and [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/coxibs-can-go-it-alone/</link>
			</item>
	<item>
		<title>&#8220;Five-in-One&#8221; Vaccine Means Fewer Injections</title>
		<description><![CDATA[A new vaccine, which is expected to be able to eliminate six of the 20 injections that babies receive before age two years, has received federal approval. Pediarix™ (GlaxoSmithKline) combines protection, into one injection, against five serious diseases—diphtheria, tetanus, whooping cough (pertussis), hepatitis B, and polio. The vaccine is to be given in a three-dose [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/five-in-one-vaccine-means-fewer-injections/</link>
			</item>
	<item>
		<title>Asthma Drug Approved for Hay Fever</title>
		<description><![CDATA[Montelukast sodium (Singulair canadian, Merck), currently on the market for asthma control, has now been approved for the relief of symptoms of hay fever, also known as seasonal allergic rhinitis. The once-a-day tablet can help to relieve a broad array of allergy symptoms for 24 hours and can be used to treat adults and children [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/asthma-drug-approved-for-hay-fever/</link>
			</item>
	<item>
		<title>Risky Glaucoma Treatment</title>
		<description><![CDATA[Older patients who are treated with topical beta blockers for glaucoma, a major cause of blindness, may be at a higher risk of airways obstruction—even if they have no history of respiratory disease, say researchers from the Institute of Ophthalmology, Royal Brompton Hospital, and Moorfields Eye Hospital, all in London. Analyzing data from 11,739 patients, [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/risky-glaucoma-treatment/</link>
			</item>
	<item>
		<title>REACH Award Announced</title>
		<description><![CDATA[Sanofi-Synthelabo and Bristol-Myers Squibb have announced the launch of the REACH (deduction of Atherothrom-bosis for Continued Health) Award Program, which aims to recognize promising work in improving the management of this disease. canadian cialis online Random Posts:Safety Alert: Does Rosiglitazone Weaken BonesOnglyza for Type-2 DiabetesOxaliplatin Approved for Metastatic Colorectal CancerRosuvastatin (Crestor): Adjunct For Slowing AtherosclerosisNew Dosage: [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/reach-award-announced/</link>
			</item>
	<item>
		<title>Combination Interferon For Chronic Hepatitis C Virus</title>
		<description><![CDATA[Pegylated interferon (peg-interferon) alfa-2a (Pegasys®, Roche), combined with ribavirin (Rebetol tablet, Schering), is now available for the treatment of patients with chronic hepatitis C virus (HCV). This combination is intended for adults with compensated liver disease and who have not previously taken alpha interferons. (Please see the December 2002 issue of P&#38;T for a review [...]]]></description>
		<link>http://www.canadiannetmall.com/blog/combination-interferon-for-chronic-hepatitis-c-virus/</link>
			</item>
</channel>
</rss>

